A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel at high risk for recurrence: PURITY study
BMC cancer, 2024-04, Vol.24 (1) [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12225-6
Full text available
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||